"Our mission is to provide you with the highest quality medical & surgical eye & retina care in a caring and compassionate manner. Advanced therapies complement our state of the art technology in tailoring treatments that improve and preserve vision."

During the past decade, Oregon Retina institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Oregon Retina institute" are "Choroidal Neovascularization" (1 trials), "Diabetic Macular Edema" (1 trials), "Macular Edema" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Oregon Retina institute" in a lesser frequency.

Most popular intervention types in "Oregon Retina institute" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "IVT aflibercept" (2 trials), "Faricimab" (1 trials), "Ranibizumab" (1 trials), "SC CLS-TA" (1 trials) and "Sham Procedure" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oregon Retina institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Oregon Retina institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Oregon Retina institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Oregon Retina institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".